The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Shares of Altimmune (NASDAQ:ALT) traded sharply higher on Friday after the obesity drug developer generated buyout rumors on ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Health-care companies fell, but not by as much as the broad market, as traders sought out defensive sectors. Some of the highest risk issues that were hit hardest in the recent correction -- including ...

The White House’s bid to install a vaccine-skeptic ally of HHS Secretary Robert F. Kennedy Jr. atop the CDC fell apart this ...

The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

Mitolyn Weight Loss Reveal: Consumer Reports Discuss Mitolyn Supplement Results ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

Crypto Password-Cracking Firm Unciphered in Turmoil Over Co-Founder’s Controversial Past ...